Merico, Daniele http://orcid.org/0000-0002-3728-4401
Spickett, Carl
O’Hara, Matthew
Kakaradov, Boyko
Deshwar, Amit G.
Fradkin, Phil
Gandhi, Shreshth
Gao, Jiexin
Grant, Solomon
Kron, Ken
Schmitges, Frank W.
Shalev, Zvi
Sun, Mark
Verby, Marta
Cahill, Matthew
Dowling, James J.
Fransson, Johan
Wienholds, Erno
Frey, Brendan J.
Article History
Received: 9 October 2019
Accepted: 6 March 2020
First Online: 8 April 2020
Competing interests
: All authors are shareholders in Deep Genomics Inc. Deep Genomics is developing an oligonucleotide therapeutic to target c.1934T > G p.Met645Arg and treat Wilson disease.